GM-CSF therapy for peripheral vascular disease
Claire Braybrook
This article has no abstract so we have provided the first paragraph of the full text.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is reported to stimulate arteriogenesis leading to improved collateral blood flow in patients with coronary artery disease. van Royen et al. have recently explored the use of this growth factor for treating patients with peripheral arterial disease.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
